BCLI / Brainstorm Cell Therapeutics Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Brainstorm Cell Therapeutics Inc.
US ˙ OTCPK ˙ US10501E2019

Jumlah Saham Beredar 10,376,109 shares
Saham Orang Dalam1,167,438 shares
Kepemilikan oleh Orang Dalam11.25 %
Orang Dalam Sejati32
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

0 ( )

7701 out of 11323

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

0.000 %( )

7620 out of 11244

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Brainstorm Cell Therapeutics Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
ACC International Holdings Ltd. - 67,053 4,470
ACCBT Corp. 3,181,925
Irit Arbel Director - [D] 41,054 41,054
Sankesh Abbhi Director - [D] 11,323 755
June Sherie Almenoff Director - [D] 6,000 400
Arturo Araya Chief Commercial Officer - [O] 8,608 574
Menghisteab Bairu Director - [D] 24,000 24,000
Yoram Bibring Chief Financial Officer - [O] 50,000 3,333
Dagher Ibrahim B. Chief Medical Officer - [O] 535,742 535,742
Jacob A Frenkel Director - [D] 43,777 43,777
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Fiorino Anthony S. Chief Executive Officer - [O] 2,500 167
Mordechai Friedman Director - [D] 0 0
Hartoun Hartounian EVP, Chief Operating Officer - [O] 52,000 52,000
Adrian Harel 70,000
Avi Israeli 133,334
Kern Ralph Dr. COO and Chief Medical Officer - [O] 223,310 14,887
Chaim Lebovits President & CEO - [O] 200,960 200,960
Stacy Lindborg Director - [D] 48,229 48,229
Nir Naor Director - [D] 31,465 31,465
Alla Patlis See Remarks - [O] 44,349 44,349
Alon Pinkas 15,333
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Polverino Anthony J. Director - [D] 25,730 25,730
Eyal Rubin CFO and Treasurer - [O] 25,000 1,667
Robert G L Shorr Director - [D] 45,731 3,049
Chen Schor Director - [D] 121,558 8,104
David Setboun EVP and COO - [O] 55,000 3,667
Preetam Shah EVP, CFO and Treasurer - [O] 11,600 773
Liat Sossover 100,000
Malcolm S Taub Director - [D] 77,332 5,155
Kirk Taylor Chief Medical Officer - [O] 35,000 2,333
Anthony Waclawski See Remarks - [O] 35,000 2,333
Uri Yablonka EVP & Chief Business Officer, Director - [D] [O] 68,464 68,464

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di BCLI / Brainstorm Cell Therapeutics Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2024-10-01 Lebovits Chaim 1,836 3.4272 122 51.4080 6,292 0 3.2500 -5,896 -93.70
2024-09-30 Lebovits Chaim 22,000 0.2280 1,467 3.4200 5,016
2024-05-28 Lebovits Chaim 15,000 0.5183 1,000 7.7745 7,774
2024-05-22 Lebovits Chaim 25,000 0.6400 1,667 9.6000 16,000
2024-05-21 Lebovits Chaim 25,000 0.5790 1,667 8.6850 14,475
2024-05-13 Lebovits Chaim 10,000 0.4900 667 7.3500 4,900
2024-05-11 Lebovits Chaim 10,000 0.4665 667 6.9975 4,665
2024-05-10 Lebovits Chaim 20,000 0.4650 1,333 6.9750 9,300
2024-05-07 Lebovits Chaim 66,300 0.3743 4,420 5.6145 24,816

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

BCLI / Brainstorm Cell Therapeutics Inc. Insider Trades
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di BCLI / Brainstorm Cell Therapeutics Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2024-07-19 Dagher Ibrahim B. 63,000 0.3503 4,200 5.2545 22,069 70 0.2225 -21,134 -95.77
2020-07-16 ACC International Holdings Ltd. 7,823 13.4668 522 202.0020 105,351
2020-07-15 ACC International Holdings Ltd. 18,430 13.1153 1,229 196.7295 241,715
2020-07-13 ACC International Holdings Ltd. 40,000 13.5238 2,667 202.8570 540,952
2020-07-10 ACC International Holdings Ltd. 2,000 13.3500 133 200.2500 26,700
2020-07-09 ACC International Holdings Ltd. 3,500 13.1253 233 196.8795 45,939
2019-08-28 ARBEL IRIT 13,332 3.6672 889 55.0080 48,891
2015-12-16 SHORR ROBERT G L 10,800 2.7100 720 40.6500 29,268
2015-12-15 TAUB MALCOLM S 11,263 2.5900 751 38.8500 29,171

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

BCLI / Brainstorm Cell Therapeutics Inc. Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas
Tanggal
Perdagangan
Tanggal
Formulir Orang Dalam Ticker Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Unit
Diubah
Nilai
Diubah (1 ribu)
Sisa
Pilihan
Sisa
Saham
2025-01-07 2025-01-01 4 Dagher Ibrahim B. BCLI Common Stock A - Award D 50,000 66,849
2025-01-07 3/A Dagher Ibrahim B. BCLI Common Stock D 315,742
2025-01-07 3/A Dagher Ibrahim B. By the Reporting Person's Roth IRA BCLI Common Stock I 160,000
2025-01-07 3/A Dagher Ibrahim B. See Note BCLI Common Stock I 30,000
2025-01-03 2025-01-01 4 Lebovits Chaim BCLI Common Stock A - Award D 120,000 200,960
2025-01-03 2025-01-01 4 FRENKEL JACOB A BCLI Common Stock A - Award D 40,000 43,777
2025-01-03 2025-01-01 4 Polverino Anthony J. BCLI Common Stock A - Award D 24,000 25,730
2025-01-03 2025-01-01 4 Yablonka Uri BCLI Common Stock A - Award D 20,000 68,464
2025-01-03 2025-01-01 4 Yablonka Uri BCLI Common Stock A - Award D 40,000 48,464
2025-01-03 2025-01-01 4 Naor Nir BCLI Common Stock A - Award D 30,666 31,465
2025-01-03 2025-01-01 4 Patlis Alla BCLI Common Stock A - Award D 40,000 44,349
2025-01-03 2025-01-01 4 HARTOUNIAN HARTOUN BCLI Common Stock A - Award D 50,000 52,000
2025-01-03 2025-01-01 4 Lindborg Stacy BCLI Common Stock A - Award D 20,000 48,229
2025-01-03 2025-01-01 4 Bairu Menghisteab BCLI Common Stock A - Award D 24,000 24,000
2025-01-03 2025-01-01 4 ARBEL IRIT BCLI Common Stock A - Award D 30,666 41,054
2024-10-02 2024-10-01 4 Lebovits Chaim BCLI Common Stock P - Purchase D 3.4272 1,836 6 80,960
2024-10-02 2024-09-30 4 Lebovits Chaim BCLI Common Stock P - Purchase D 0.2280 22,000 5 1,186,865
2024-07-31 2024-05-22 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.6400 25,000 16 1,149,865
2024-07-31 2024-05-21 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.5790 25,000 14 1,124,865
2024-07-31 2024-05-28 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.5183 15,000 8 1,164,865
2024-07-31 2024-05-13 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.4900 10,000 5 1,099,865
2024-07-31 2024-05-11 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.4665 10,000 5 1,089,865
2024-07-31 2024-05-10 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.4650 20,000 9 1,079,865
2024-07-31 2024-05-06 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.3753 135,000 51 993,565
2024-07-31 2024-05-07 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.3743 66,300 25 1,059,865
2024-07-31 2024-04-19 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.5199 15,000 8 858,565
2024-07-31 2024-04-18 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.5255 115,072 60 843,565
2024-07-31 2024-04-17 4/A Lebovits Chaim BCLI Common Stock P - Purchase D 0.5457 130,000 71 728,493
2024-07-24 2024-07-19 4 Dagher Ibrahim B. BCLI Common Stock S - Sale D 0.3503 -63,000 -22 0
2024-06-25 2024-06-24 4 HARTOUNIAN HARTOUN BCLI Common Stock A - Award D 30,000 30,000
2024-06-03 2024-05-28 4 Lebovits Chaim BCLI Common Stock A - Award D 0.5183 15,000 8 1,164,865
2024-05-23 2024-05-22 4 Lebovits Chaim BCLI Common Stock A - Award D 0.6400 25,000 16 1,149,865
2024-05-23 2024-05-21 4 Lebovits Chaim BCLI Common Stock A - Award D 0.5790 25,000 14 1,124,865
2024-05-14 2024-05-13 4 Lebovits Chaim BCLI Common Stock A - Award D 0.4900 10,000 5 1,099,865
2024-05-14 2024-05-11 4 Lebovits Chaim BCLI Common Stock A - Award D 0.4665 10,000 5 1,089,865
2024-05-14 2024-05-10 4 Lebovits Chaim BCLI Common Stock A - Award D 0.4650 20,000 9 1,079,865
2024-05-07 2024-05-07 4 Lebovits Chaim BCLI Common Stock A - Award D 0.3743 66,300 25 1,059,865
2024-05-07 2024-05-06 4 Lebovits Chaim BCLI Common Stock A - Award D 0.3753 135,000 51 993,565
2024-04-25 2024-04-19 4 Lebovits Chaim BCLI Common Stock A - Award D 0.5199 15,000 8 858,565
2024-04-22 3 Dagher Ibrahim B. BCLI Common Stock D 63,000
2024-04-22 3 Dagher Ibrahim B. See Note BCLI Common Stock I 30,000
2024-04-22 3 Dagher Ibrahim B. By the Reporting Person's Roth IRA BCLI Common Stock I 160,000
2024-04-19 2024-04-18 4 Lebovits Chaim BCLI Common Stock A - Award D 0.5255 115,072 60 843,565
2024-04-19 2024-04-17 4 Lebovits Chaim BCLI Common Stock A - Award D 0.5457 130,000 71 728,493
2024-03-13 2024-03-11 4 Lindborg Stacy BCLI Common Stock A - Award D 241,935 423,435
2024-03-13 2024-03-11 4 Yablonka Uri BCLI Common Stock A - Award D 109,426 126,969
2024-03-13 2024-03-11 4 Patlis Alla BCLI Common Stock A - Award D 65,246 65,246
2024-03-13 2024-03-11 4 Lebovits Chaim BCLI Common Stock A - Award D 305,198 598,493
2023-09-05 2023-09-01 4 Lindborg Stacy BCLI Common Stock P - Purchase D 1.7741 11,500 20 181,500
2023-08-07 2023-08-02 4 Lindborg Stacy BCLI Common Stock A - Award D 35,000 170,000
2023-08-04 2023-08-02 4 Lebovits Chaim BCLI Common Stock A - Award D 31,185 293,295
2023-06-21 2023-06-19 4 Naor Nir BCLI Common Stock A - Award D 11,999 11,999
2023-05-01 2023-05-01 4 Taylor Kirk BCLI Common Stock A - Award D 35,000 35,000
2023-04-24 2023-04-20 4 Lebovits Chaim BCLI Common Stock A - Award D 75,000 262,110
2023-04-24 2023-04-20 4 Lindborg Stacy BCLI Common Stock A - Award D 75,000 135,000
2023-01-04 2022-12-07 4 Lindborg Stacy BCLI Common Stock A - Award D 35,000 60,000
2023-01-04 2022-09-18 4 Lebovits Chaim BCLI Common Stock A - Award D 31,185 187,110
2022-04-08 2022-04-06 4 FRENKEL JACOB A BCLI Stock Option (right to buy) A - Award D 0.75 50,000 50,000
2022-03-14 2022-03-06 4 Kern Ralph Dr. BCLI Common Stock A - Award D 35,885 223,310
2022-02-03 2022-02-01 4 Polverino Anthony J. BCLI Common Stock A - Award D 3,882 25,960
2021-12-17 2021-12-15 4 Polverino Anthony J. BCLI Common Stock A - Award D 2,000 22,078
2021-12-17 2021-12-15 4 TAUB MALCOLM S BCLI Common Stock A - Award D 12,000 77,332
2021-12-17 2021-12-15 4 Almenoff June Sherie BCLI Common Stock A - Award D 2,000 6,000
2021-12-17 2021-12-15 4 Yablonka Uri BCLI Stock Option (right to buy) A - Award D 0.75 13,333 13,333
2021-12-17 2021-12-15 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 25,333 25,333
2021-12-10 2021-12-10 4 Kern Ralph Dr. BCLI Common Stock A - Award D 35,885 187,425
2021-12-10 2021-12-10 4 TAUB MALCOLM S BCLI Common Stock A - Award D 12,000 65,332
2021-12-10 2021-12-10 4 Lebovits Chaim BCLI Common Stock A - Award D 31,185 155,925
2021-12-10 2021-12-10 4 Polverino Anthony J. BCLI Common Stock A - Award D 2,000 20,078
2021-12-10 2021-12-10 4 Polverino Anthony J. BCLI Common Stock A - Award D 2,216 18,078
2021-12-10 2021-12-10 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 25,333 25,333
2021-12-10 2021-12-10 4 Yablonka Uri BCLI Stock Option (right to buy) A - Award D 0.75 13,333 13,333
2021-12-10 2021-12-10 4 Abbhi Sankesh BCLI Common Stock A - Award D 6,666 11,323
2021-12-10 2021-12-10 4 FRENKEL JACOB A BCLI Stock Option (right to buy) A - Award D 0.75 50,000 50,000
2021-12-10 2021-12-10 4 Almenoff June Sherie BCLI Common Stock A - Award D 2,000 4,000
2020-12-31 2020-12-30 4 Shah Preetam BCLI Common Stock F - Taxes D 4.6400 -25,000 -116 11,600
2020-11-19 2020-11-17 4 Lindborg Stacy BCLI Call Option (right to buy) P - Purchase D 10.00 11,000.0000 200 2,200 200
2020-09-10 2020-09-08 4 Waclawski Anthony BCLI Stock Option (Right to Buy) A - Award D 12.58 80,000 80,000
2020-09-10 2020-09-08 4 Waclawski Anthony BCLI Common Stock A - Award D 35,000 35,000
2020-07-31 2020-07-26 4 Lebovits Chaim BCLI Common Stock A - Award D 31,185 124,740
2020-07-16 2020-07-15 4 Abbhi Sankesh Abbhi Investments, LLC BCLI Common Stock P - Purchase I 12.9900 46,779 608 2,164,530
2020-07-16 2020-07-16 4 Setboun David BCLI Common Stock P - Purchase D 12.9480 5,000 65 55,000
2020-07-16 2020-07-16 4 ACC International Holdings Ltd. BCLI Common Stock S - Sale D 13.4668 -7,823 -105 67,053
2020-07-16 2020-07-15 4 ACC International Holdings Ltd. BCLI Common Stock S - Sale D 13.1153 -18,430 -242 74,876
2020-07-16 2020-07-13 4 ACC International Holdings Ltd. BCLI Common Stock S - Sale D 13.5238 -40,000 -541 93,306
2020-07-16 2020-07-10 4 ACC International Holdings Ltd. BCLI Common Stock S - Sale D 13.3500 -2,000 -27 133,306
2020-07-16 2020-07-09 4 ACC International Holdings Ltd. BCLI Common Stock S - Sale D 13.1253 -3,500 -46 135,306
2020-06-26 2020-06-23 4 Yablonka Uri BCLI Common Stock A - Award D 10,000 17,543
2020-06-01 2020-06-01 4 Lindborg Stacy BCLI Stock Option (right to buy) A - Award D 7.67 100,000 100,000
2020-06-01 2020-06-01 4 Lindborg Stacy BCLI Common Stock A - Award D 25,000 25,000
2020-04-07 2020-04-06 4 FRENKEL JACOB A BCLI Stock Option (right to buy) A - Award D 0.75 50,000 50,000
2020-04-07 2020-04-07 4 Setboun David BCLI Common Stock A - Award D 50,000 50,000
2020-04-07 3 Abbhi Sankesh Abbhi Investments, LLC BCLI Common Stock I 4,235,502
2020-04-07 3 Abbhi Sankesh Abbhi Investments, LLC BCLI Common Stock I 4,235,502
2020-04-07 3 Abbhi Sankesh Abbhi Investments, LLC BCLI Common Stock I 4,235,502
2020-04-07 2020-04-06 4 Abbhi Sankesh BCLI Common Stock A - Award D 4,657 4,657
2020-04-07 3 FRENKEL JACOB A BCLI Common Stock D 113,334
2020-04-07 3 FRENKEL JACOB A BCLI Common Stock D 113,334
2020-04-07 3 FRENKEL JACOB A BCLI Common Stock D 113,334
2020-03-13 2020-03-09 4 Kern Ralph Dr. BCLI Stock Option (right to buy) A - Award D 7.33 80,000 80,000
2020-03-06 2020-03-06 4 Kern Ralph Dr. BCLI Common Stock A - Award D 35,885 151,540
2020-02-14 2019-12-12 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 25,333 25,333
2020-02-14 2019-12-12 4 TAUB MALCOLM S BCLI Common Stock A - Award D 12,000 53,332
2020-02-14 2019-12-12 4 Yablonka Uri BCLI Stock Option (right to buy) A - Award D 0.75 13,333 13,333
2020-02-14 2019-12-12 4 Almenoff June Sherie BCLI Common Stock A - Award D 2,000 2,000
2020-02-14 2020-02-01 4 Polverino Anthony J. BCLI Common Stock A - Award D 3,071 15,862
2020-02-14 2019-12-12 4 Polverino Anthony J. BCLI Common Stock A - Award D 2,000 12,791
2019-12-27 2019-12-24 4 Araya Arturo BCLI Common Stock P - Purchase D 3.9000 3,000 12 8,608
2019-12-27 2019-12-24 4 Shah Preetam BCLI Common Stock P - Purchase D 3.9594 11,600 46 36,600
2019-12-27 2019-12-24 4 Kern Ralph Dr. BCLI Common Stock P - Purchase D 3.8800 3,000 12 115,655
2019-09-09 2019-09-06 4 Shah Preetam BCLI Stock Option (right to buy) A - Award D 3.96 100,000 100,000
2019-09-09 2019-09-06 4 Shah Preetam BCLI Stock Option (right to buy) A - Award D 6.00 100,000 100,000
2019-09-09 2019-09-06 4 Shah Preetam BCLI Common Stock A - Award D 25,000 25,000
2019-08-30 2019-08-28 4 ARBEL IRIT BCLI Stock Option (right to buy) M - Exercise D 2.25 -6,666 0
2019-08-30 2019-08-28 4 ARBEL IRIT BCLI Stock Option (right to buy) M - Exercise D 2.25 -6,666 0
2019-08-30 2019-08-28 4 ARBEL IRIT BCLI Common Stock S - Sale D 3.6672 -13,332 -49 155,833
2019-08-30 2019-08-28 4 ARBEL IRIT BCLI Common Stock M - Exercise D 2.2500 6,666 15 169,165
2019-08-30 2019-08-28 4 ARBEL IRIT BCLI Common Stock M - Exercise D 2.2500 6,666 15 169,165
2019-07-26 2019-07-26 4 Lebovits Chaim BCLI Common Stock A - Award D 31,185 2,166,155
2019-03-08 2019-03-06 4 Kern Ralph Dr. BCLI Common Stock A - Award D 35,885 112,655
2019-02-22 2019-02-01 4 Polverino Anthony J. BCLI Common Stock A - Award D 3,501 10,791
2019-01-08 2019-01-04 4 Almenoff June Sherie By Meadowlark Management LLC BCLI Common Stock P - Purchase I 3.3900 1,475 5 7,175
2018-12-21 2018-10-24 4 Schor Chen By The C. Schor Irrevocable Trust BCLI Common Stock G - Gift I 121,558 121,558
2018-12-21 2018-10-24 4 Schor Chen BCLI Common Stock G - Gift D -121,558 4,000
2018-11-30 2018-11-30 4 TAUB MALCOLM S BCLI Common Stock A - Award D 12,000 41,332
2018-11-30 2018-11-30 4 Yablonka Uri BCLI Stock Option (right to buy) A - Award D 0.75 13,333 13,333
2018-11-30 2018-11-30 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 25,333 25,333
2018-11-30 2018-11-30 4 Polverino Anthony J. BCLI Common Stock A - Award D 1,667 7,290
2018-11-30 2018-11-30 4 Polverino Anthony J. BCLI Common Stock A - Award D 2,000 5,623
2018-11-30 2018-11-30 4 Schor Chen BCLI Common Stock A - Award D 2,000 125,558
2018-09-04 2018-08-28 4 Araya Arturo BCLI Stock Option (right to buy) A - Award D 3.98 200,000 200,000
2018-09-04 2018-08-28 4 Araya Arturo BCLI Common Stock D - Sale to Issuer D -2,805 5,608
2018-07-27 2018-07-26 4 Lebovits Chaim BCLI Common Stock A - Award D 31,185 2,134,970
2018-03-26 2018-03-06 4 Kern Ralph Dr. BCLI Common Stock A - Award D 35,885 76,770
2018-03-26 2018-03-26 4 Araya Arturo BCLI Common Stock A - Award D 1,249 8,413
2018-03-20 2018-03-15 4/A Kern Ralph Dr. BCLI Common Stock P - Purchase D 3.5994 5,000 18 40,885
2018-03-20 2018-03-15 4/A Almenoff June Sherie By Meadowlark Management LLC BCLI Common Stock P - Purchase I 3.5000 5,700 20 5,700
2018-03-19 2018-03-15 4 Kern Ralph Dr. BCLI Common Stock A - Award D 3.5994 5,000 18 40,885
2018-03-16 2018-03-15 4 Almenoff June Sherie By Meadowlark Management LLC BCLI Common Stock A - Award I 3.5000 5,700 20 5,700
2018-02-28 2018-02-26 4 Araya Arturo BCLI Common Stock A - Award D 4,152 7,164
2018-02-05 2018-02-01 4 Polverino Anthony J. BCLI Common Stock A - Award D 3,623 3,623
2017-11-20 2017-11-20 4 Rubin Eyal BCLI Stock Option (right to buy) A - Award D 4.30 93,686 93,686
2017-11-20 2017-11-20 4 Rubin Eyal BCLI Common Stock A - Award D 25,000 25,000
2017-11-13 2017-11-10 4 Schor Chen BCLI Common Stock A - Award D 2,000 123,558
2017-11-13 2017-11-10 4 TAUB MALCOLM S BCLI Common Stock A - Award D 12,000 29,332
2017-11-13 2017-11-10 4 Yablonka Uri BCLI Stock Option (right to buy) A - Award D 0.75 13,333 13,333
2017-11-13 2017-11-10 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 25,333 25,333
2017-11-13 2017-11-10 4 SHORR ROBERT G L BCLI Common Stock A - Award D 8,666 45,731
2017-08-31 2017-08-31 4 ARBEL IRIT BCLI Common Stock P - Purchase D 4.2600 2,500 11 155,833
2017-08-23 2017-08-23 4 Yablonka Uri BCLI Common Stock P - Purchase D 3.9800 2,000 8 7,543
2017-07-26 2017-07-26 4 Lebovits Chaim BCLI Stock Option (right to buy) A - Award D 4.81 41,580 41,580
2017-07-26 2017-07-26 4 Lebovits Chaim BCLI Common Stock A - Award D 31,185 2,103,785
2017-07-17 2017-07-13 4 Yablonka Uri BCLI Common Stock A - Award D 5,543 5,543
2017-07-17 2017-07-13 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 12,000 12,000
2017-03-06 2017-03-06 4 Kern Ralph Dr. BCLI Stock Option (right to buy) A - Award D 4.18 47,847 47,847
2017-03-06 2017-03-06 4 Kern Ralph Dr. BCLI Common Stock A - Award D 35,885 35,885
2017-03-03 2017-02-26 4 Araya Arturo BCLI Common Stock A - Award D 3,012 3,012
2017-02-28 2017-02-26 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 6,667 6,667
2016-06-23 2016-06-22 4 SHORR ROBERT G L BCLI Common Stock A - Award D 8,666 37,065
2016-06-23 2016-06-22 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 25,333 25,333
2016-06-23 2016-06-22 4 TAUB MALCOLM S BCLI Common Stock A - Award D 8,666 17,332
2016-06-23 2016-06-22 4 Pinkas Alon BCLI Stock Option (right to buy) A - Award D 0.75 15,333 15,333
2016-06-23 2016-06-22 4 Friedman Mordechai BCLI Stock Option (right to buy) A - Award D 0.75 16,666 16,666
2016-06-23 2016-06-22 4 Yablonka Uri BCLI Stock Option (right to buy) A - Award D 0.75 13,333 13,333
2015-12-17 2015-12-16 4 SHORR ROBERT G L BCLI Common Stock S - Sale D 2.7100 -10,800 -29 28,399
2015-12-16 2015-12-14 4 Friedman Mordechai BCLI Stock Option (right to buy) M - Exercise D 0.75 -5,000 11,666
2015-12-16 2015-12-14 4 Friedman Mordechai BCLI Common Stock S - Sale D 2.5700 -5,000 -13 0
2015-12-16 2015-12-14 4 Friedman Mordechai BCLI Common Stock M - Exercise D 0.7500 5,000 4 5,000
2015-12-16 2015-12-15 4 TAUB MALCOLM S BCLI Common Stock S - Sale D 2.5900 -11,263 -29 8,666
2015-12-16 2015-12-14 4 TAUB MALCOLM S BCLI Common Stock S - Sale D 2.6100 -30,479 -80 19,929
2015-12-14 2015-12-11 4 TAUB MALCOLM S BCLI Common Stock S - Sale D 2.6600 -980 -3 50,408
2015-12-14 2015-12-10 4 TAUB MALCOLM S BCLI Common Stock S - Sale D 2.7400 -12,500 -34 51,388
2015-12-14 2015-12-11 4 SHORR ROBERT G L BCLI Common Stock S - Sale D 2.5600 -5,300 -14 39,199
2015-12-14 2015-12-10 4 SHORR ROBERT G L BCLI Common Stock S - Sale D 2.7100 -5,500 -15 44,499
2015-12-03 2015-12-01 4 Bibring Yoram BCLI Stock Option (right to buy) D - Sale to Issuer D 3.17 82,500 82,500
2015-10-13 2015-09-28 4/A Lebovits Chaim BCLI Stock Option (right to buy) A - Award D 2.45 369,619 369,619
2015-10-02 2015-10-01 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 2.5800 2,000 5 138,806
2015-10-01 2015-09-28 4 Lebovits Chaim BCLI Stock Option (right to buy) A - Award D 2.45 369,619 369,619
2015-10-01 2015-09-30 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 2.3400 9,200 22 136,806
2015-08-31 2015-08-27 4 SHORR ROBERT G L BCLI Common Stock A - Award D 8,666 49,999
2015-08-31 2015-08-27 4 Yablonka Uri BCLI Stock Option (right to buy) A - Award D 0.75 13,333 13,333
2015-08-31 2015-08-27 4 TAUB MALCOLM S BCLI Common Stock A - Award D 8,666 50,554
2015-08-31 2015-08-27 4 Pinkas Alon BCLI Stock Option (right to buy) A - Award D 0.75 15,333 15,333
2015-08-31 2015-08-27 4 Friedman Mordechai BCLI Stock Option (right to buy) A - Award D 0.75 16,666 16,666
2015-08-31 2015-08-27 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 25,333 25,333
2015-08-21 2015-08-20 4 Bibring Yoram BCLI Common Stock P - Purchase D 3.0400 8,500 26 50,000
2015-08-19 2015-08-17 4 Bibring Yoram BCLI Common Stock P - Purchase D 2.9200 41,500 121 41,500
2015-08-03 2015-07-30 4 Bibring Yoram BCLI Stock Option (right to buy) A - Award D 3.17 165,000 165,000
2015-06-03 2015-06-01 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.75 6,667 6,667
2015-05-05 2015-05-03 4 Schor Chen BCLI Common Stock A - Award D 60,000 121,558
2014-10-15 2014-10-15 4 Fiorino Anthony S. BCLI Common Stock P - Purchase D 3.5990 300 1 2,500
2014-10-15 2014-10-15 4 Fiorino Anthony S. BCLI Common Stock P - Purchase D 3.5900 200 1 2,200
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 3.9999 300 1 127,606
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 3.9499 700 3 127,306
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 3.9500 300 1 126,606
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.0100 400 2 126,306
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 3.9799 400 2 125,906
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 3.9799 1,300 5 125,506
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.0099 600 2 124,206
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.0399 600 2 123,606
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.0500 300 1 123,006
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.0799 200 1 122,706
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.0899 2,500 10 122,506
2014-10-15 2014-10-10 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.2900 1,000 4 120,006
2014-10-01 2014-10-01 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.0799 3,600 15 119,006
2014-10-01 2014-09-30 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.3200 1,000 4 115,406
2014-10-01 2014-09-30 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.2150 500 2 114,406
2014-10-01 2014-09-29 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.1200 1,000 4 113,906
2014-10-01 2014-09-29 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.1700 500 2 112,906
2014-10-01 2014-09-29 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.1800 100 0 112,406
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.3000 1,800 8 112,306
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.2900 2,000 9 110,506
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.2800 400 2 108,506
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.2700 1,000 4 108,106
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.2300 1,200 5 107,106
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.2000 500 2 105,906
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.1800 300 1 105,406
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.1400 500 2 105,106
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.1000 300 1 104,606
2014-09-24 2014-09-22 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 4.0500 500 2 104,306
2014-09-24 2014-09-19 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 3.9400 1,000 4 103,806
2014-09-24 2014-09-19 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 3.9000 1,500 6 102,806
2014-09-19 2014-09-18 4 Fiorino Anthony S. BCLI Common Stock P - Purchase D 3.8400 800 3 2,000
2014-09-16 2014-09-15 4 Fiorino Anthony S. BCLI Common Stock P - Purchase D 0.2835 3,000 1 18,000
2014-09-16 2014-09-15 4 Fiorino Anthony S. BCLI Common Stock P - Purchase D 0.2875 5,000 1 15,000
2014-09-16 2014-09-12 4 Fiorino Anthony S. BCLI Common Stock P - Purchase D 0.2850 7,500 2 10,000
2014-09-16 2014-09-12 4 Fiorino Anthony S. BCLI Common Stock P - Purchase D 0.2800 2,500 1 2,500
2014-08-19 2014-08-15 4 SHORR ROBERT G L BCLI Common Stock A - Award D 130,000 620,000
2014-08-19 2014-08-15 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.05 380,000 380,000
2014-08-19 2014-08-15 4 TAUB MALCOLM S BCLI Common Stock A - Award D 130,000 628,333
2014-08-19 2014-08-15 4 Pinkas Alon BCLI Stock Option (right to buy) A - Award D 0.05 230,000 230,000
2014-08-19 2014-08-15 4 Friedman Mordechai BCLI Stock Option (right to buy) A - Award D 0.05 250,000 250,000
2014-08-19 2014-08-15 4 Yablonka Uri BCLI Stock Option (right to buy) A - Award D 0.05 200,000 200,000
2014-06-20 2014-06-16 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 0.2900 130,000 38 1,519,600
2014-06-16 2014-06-13 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 0.3500 150,000 52 1,389,600
2014-06-10 2014-06-09 4 Fiorino Anthony S. BCLI Stock Option (right to buy) A - Award D 0.30 5,700,000 5,700,000
2014-06-09 2014-06-06 4 Yablonka Uri BCLI Stock Option (right to buy) A - Award D 0.18 500,000 500,000
2014-05-02 2014-04-28 4 ACC International Holdings Ltd. BCLI Common Stock P - Purchase D 0.3000 939,600 282 1,239,600
2014-04-14 2014-04-13 4 Israeli Avi BCLI Stock Option (right to buy) A - Award D 133,334 133,334
2014-04-14 2014-04-13 4 Israeli Avi BCLI Stock Option (right to buy) A - Award D 166,666 166,666
2014-01-03 2013-12-31 4 Sossover Liat BCLI Stock Option (right to buy) A - Award D 0.18 100,000 100,000
2013-04-23 2013-04-19 4 SHORR ROBERT G L BCLI Common Stock A - Award D 130,000 490,000
2013-04-23 2013-04-19 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.15 180,000 180,000
2013-04-23 2013-04-19 4 TAUB MALCOLM S BCLI Common Stock A - Award D 130,000 498,333
2013-04-23 2013-04-13 4 Israeli Avi BCLI Stock Option (right to buy) A - Award D 166,666 166,666
2013-04-23 2013-04-19 4 Pinkas Alon BCLI Stock Option (right to buy) A - Award D 0.15 130,000 130,000
2013-04-23 2013-04-19 4 Friedman Mordechai BCLI Stock Option (right to buy) A - Award D 0.15 150,000 150,000
2012-09-06 2012-08-01 4 ARBEL IRIT BCLI Stock Option (right to buy) A - Award D 0.15 180,000 180,000
2012-09-06 2012-08-01 4 Pinkas Alon BCLI Stock Option (right to buy) A - Award D 0.15 130,000 130,000
2012-09-06 2012-08-01 4 Friedman Mordechai BCLI Stock Option (right to buy) A - Award D 0.15 150,000 150,000
2012-08-27 2012-08-01 4/A Harel Adrian BCLI Stock Option (right to buy) A - Award D 0.26 70,000 70,000
2012-08-27 2012-08-01 4/A Sossover Liat BCLI Stock Option (right to buy) A - Award D 0.26 60,000 60,000
2012-08-03 2012-08-01 4 SHORR ROBERT G L BCLI Common Stock A - Award D 130,000 360,000
2012-08-03 2012-08-01 4 TAUB MALCOLM S BCLI Common Stock A - Award D 130,000 368,333
2012-08-03 2012-08-01 4 Sossover Liat BCLI Stock Option (right to buy) A - Award D 0.26 60,000 60,000
2012-08-03 2012-08-01 4 Harel Adrian BCLI Stock Option (right to buy) A - Award D 0.26 70,000 70,000
2012-04-17 2012-04-13 4 Israeli Avi BCLI Stock Option (right to buy) A - Award D 166,666 166,666
2009-04-03 3 TAUB MALCOLM S BCLI Common Stock D 1,250,000
2007-08-08 2007-08-02 4 ACCBT Corp. BCLI Right to Acquire Warrant to Purchase Common Stock P - Purchase D 636,385.00 3,181,925 3,181,925
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
Other Listings
DE:GHD
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista